Akeso Health Sciences, LLC v. H and H Wholesale Services, Inc.
2:16-cv-08884
Overview
Parties
Defendant
H and H Wholesale Services Inc Operating Company
Represented By
1 Attorneys ListedTonkon Torp LLP
888 SW Fifth Avenue Suite 1600, Portland, OR 97204
Plaintiff
Akeso Health Sciences, LLC Operating Company
Represented By
1 Attorneys ListedNixon Peabody LLP
300 South Grand Avenue Suite 4100, Los Angeles, CA 90071-3151
Court & Judges
Court
District Court, C.D. California (cacd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 8 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πͺπΊ European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| πͺπΊ European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| π―π΅ Japan | Japan Counterpart | View Official Patent → | |
| π―π΅ Japan | Japan Counterpart | View Official Patent → | |
| π©πͺ Germany | Germany Counterpart | View Official Patent → | |
| π PCT International (WIPO) | PCT World Application | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6068999
Dietary supplement for supporting cerebrovascular tone and treating migraine headaches
|
Filed: 1998-06-25
Issued: 2000-05-30
|
Expired (Term Ended)
Expires: 2018-06-25
|
|
|
US6500450
Composition for treating migraine headaches
|
Filed: 2000-04-27
Issued: 2002-12-31
|
Expired (Term Ended)
Expires: 2020-04-27
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).